Article
Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers.
European journal of human genetics : EJHG - 1 Feb 2010
Christiaans Imke, Kok Tjitske M, van Langen Irene M, Birnie Erwin, Bonsel Gouke J, Wilde Arthur A M, Smets Ellen M A
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is a common hereditary heart disease associated with increased mortality. Disclosure of DNA test results may have social implications such as low access to insurance. In The Netherlands, insurance companies are restricted in the use of genetic information of thei...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
